DH - NASDAQ
Definitive Healthcare Corp.
$0.90
+3.5%Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
At a Glance
Live SnapshotDefinitive Healthcare Corp. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Cash Flow Quality Insight
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
Definitive Healthcare Corp. Cash Flow Statement
DH • NASDAQ
| Definitive Healthcare Corp. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||
-199.3M | -591.4M | -202.4M | -22.3M | -62.3M | -52.6M | -36.4M | |
56.1M | 51.7M | 51.8M | 56.9M | 59.9M | 59.6M | 33.5M | |
-10.9M | -119.6M | -18.7M | -26.7M | -587K | 0.0 | -74.3M | |
29.1M | 38.1M | 48.7M | 36.4M | 10M | 1.7M | 6.6M | |
188.1M | 705.4M | 192.2M | 13.1M | 20.7M | 14.6M | 79.8M | |
(0.0) | (0.0) | (136K) | (0.0) | (13K) | (0.0) | (0.0) | |
-9.4M | -25.9M | -30.4M | -22M | -2.5M | -147K | 12.4M | |
53.8M | 58.2M | 41.2M | 35.6M | 25.2M | 23.2M | 21.6M | |
INVESTING ACTIVITIES | |||||||
-16.7M | -12.3M | -3M | -8.3M | -6.7M | -1.4M | -1.9M | |
(0.0) | -13.5M | -45M | -56.3M | -40M | -22.5M | -1.1B | |
-64.1M | -304.3M | -259.2M | -338M | (0.0) | (0.0) | (0.0) | |
234.7M | 303.8M | 275.4M | 153.7M | 0.0 | 0.0 | 0.0 | |
(153.9M) | -26.4M | -31.8M | -248.9M | -46.7M | -23.9M | -1.1B | |
FINANCING ACTIVITIES | |||||||
-49.5M | -22.4M | -30K | -1.7M | 603.2M | 0.0 | 0.0 | |
-79.5M | -13.8M | -8.6M | -6.9M | -199.5M | 13.5M | 448.9M | |
-3.1M | -5.1M | -12.3M | -12.9M | -8.1M | -2.9M | -7M | |
-49.5M | -22.4M | (0.0) | (0.0) | -231.8M | (0.0) | -1.1B | |
-18.7M | -15.5M | -4.7M | -5.2M | -11.2M | 6.1M | 682.7M | |
-150.8M | -56.7M | -25.6M | -26.7M | 384.4M | 16.7M | 1.1B | |
CASH FLOW SUMMARY | |||||||
1.4M | -636K | 218K | -544K | -129K | 146K | 19.4M | |
58.2M | -25.6M | -16M | -240.6M | 362.7M | 16.2M | 25.7M | |
105.4M | 131M | 146.9M | 387.5M | 24.8M | 8.6M | -17.1M | |
163.6M | 105.4M | 131M | 146.9M | 387.5M | 24.8M | 8.6M | |
37.1M | 45.9M | 38.2M | 27.3M | 18.5M | 21.8M | 19.7M |
SEC Filings
DH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 09, 2026 | April 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 03, 2026 | March 30, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 07, 2025 | June 30, 2025 | 2025 |
Related Guides
Continue your DH research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.